Researchers analyzed viral samples from Boston early in the pandemic to study transmission events, including at a large international conference held there.
Through this partnership, the companies hope to help oncologists make better testing and treatment decisions, as well as improve clinical trial matching.
The partners are starting by testing patients with colorectal and thyroid cancers using the 648-gene Tempus xT assay, but could expand to other areas in the future.
The group aims to determine the feasibility of TROLL-2 and TROLL-3 as diagnostic biomarkers for the prediction of treatment efficacy and prognosis in breast cancer.
The facility will use Octant's SwabSeq RNA amplicon sequencing protocol, which involves a single-step RT-PCR reaction of a few amplicons, followed by sequencing.
The firm will scale US-based testing capacity for its LiquidHallmark liquid biopsy assay, which uses amplicon-based technology to detect cancer-related mutations.
With the EUA, LabCorp is able to sell the test kit directly to consumers without a prescription, making it the first over-the-counter COVID-19 test in the US.
The company said clinical services revenues rose 66 percent during the quarter, driven by significant year-over-year growth in the volume of accessions.
With clinical sequencing data for almost 400 appendiceal cancer cases, researchers identified somatic differences in individuals diagnosed with the disease before the age of 50.
The firm said its test fits in the palm of a hand and delivers results in 30 minutes by detecting bacterial nucleic acid in throat, nasal, or nasopharyngeal swabs.
The partners will also collaborate on a study, to be peer reviewed, that will evaluate how insurance coverage of WGS affects patient care and healthcare costs.
An advisory panel to the US Food and Drug Administration voted for authorizing Pfizer and BioNTech's SARS-CoV-2 vaccine, the Wall Street Journal reports.
Early trial data of a Sanofi and GlaxoSmithKline SARS-CoV-2 vaccine indicates an insufficient immune response among older participants, according to Reuters.
In Science this week: CRISPR and expression-reported sequencing approach to trace genetic interactions, sample preparation platform for single-cell sequencing, and more.
